Travoprost/timolol
Wokɔ nnuro adwasuo a, edin a wɔde nim Travoprost/timolol, ne . Wɔde sa ani yareɛ a wɔfrɛ no glaucoma.[1][2][3][4] Adeɛ bi a wɔfrɛ no travoprost ne timolol maleate wɔ mu.[1]
Afe mpem mmienu ne nsia no mu na European Unionfoɔ gye too mu sɛ wɔmfa nsa yadeɛ.[1]
Beaeɛ a Menyaa Mmoa Firiiɛ
[sesa]- ↑ 1.0 1.1 1.2 "Duotrav EPAR". European Medicines Agency (EMA). 17 September 2018. Retrieved 30 October 2020.
- ↑ Cheng JW, Cheng SW, Gao LD, Lu GC, Wei RL (2012). "Intraocular pressure-lowering effects of commonly used fixed-combination drugs with timolol: a systematic review and meta-analysis". PLOS ONE. 7 (9): e45079. Bibcode:2012PLoSO...745079C. doi:10.1371/journal.pone.0045079. PMC 3441590. PMID 23028770.
- ↑ Konstas AG, Quaranta L, Realini T (April 2012). "Overview of the [corrected] travoprost /timolol BAK-free fixed combination". Expert Opinion on Pharmacotherapy. 13 (5): 757–66. doi:10.1517/14656566.2012.662485. PMID 22360540. S2CID 24160793.
- ↑ Denis P (February 2011). "Travoprost/timolol fixed combination in the management of open-angle glaucoma: a clinical review". Expert Opinion on Pharmacotherapy. 12 (3): 463–71. doi:10.1517/14656566.2011.551007. PMID 21254951. S2CID 46258207.